Penetrium Bioscience Inc. 187660

KRX · South Korea · Health Services

KRW 7,540.00-160.00 (-2.08%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Penetrium Bioscience Inc. 187660

KRX · South Korea · Health Services

KRW 7,540.00-160.00 (-2.08%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-35.17% · 6MFull-screen chart

Open KRW 7,800.00High KRW 8,240.00Low KRW 7,180.00Close KRW 7,540.00Volume 1.62M

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: KRW 7,700.00
Volume: 0
Market cap: KRW 487.28B
Avg. volume (1Y): 4.18M

Performance

1 week

+10.23%

1 month

+52.94%

3 months

+56.92%

6 months

-33.16%

Year to date

+202.81%

1 year

+216.81%

Total return, dividends included.

Company profile

Sector: Health Services
Industry: Medical/Nursing Services
Country: South Korea
Exchange: KRX
Shares outstanding: 63.28M
Employees: 110
ISIN: KR7187660006
Beta: 1.90

Technical view

Above averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceApr 17, 2026

Penetrium Bioscience Unveils Breakthrough Mechanism Solving 137-Year-Old "Seed & Soil" Paradigm, Opening a New Era for Targeted Cancer Therapy

Penetrium Bioscience (KOSDAQ 187660) today announced compelling new scientific evidence demonstrating, for the first time at the cellular level, the underlying mechanism behind the long-standing "Seed & Soil" theory originally proposed by Stephen Paget in 1889. The findings reveal how pathological tumor microenvironments ("soil") fundamentally limit the efficacy of targeted therapies—and how Penetrium's novel approach overcomes this barrier.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.